Login
Search
Search
0 Dates
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Ventricular Pacing Rate and Ventricular Pacing Dependency in patients requiring Permanent Pacemaker implantation after Transcatheter Aortic Valve Replacement
Session:
SESSÃO DE COMUNICAÇÕES ORAIS 05 – AVANÇOS NA GESTÃO DO RITMO CARDÍACO: UM OLHAR SOBRE AS INOVAÇÕES E OS RESULTADOS DO PACING
Speaker:
Miguel Caramelo Abrantes de Figueiredo
Congress:
CPC 2025
Topic:
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
Theme:
15. Valvular Heart Disease
Subtheme:
15.4 Valvular Heart Disease – Treatment
Session Type:
Comunicações Orais
FP Number:
---
Authors:
Miguel Abrantes De Figueiredo; Inês Rodrigues; Fernando Ferreira; Mariana Coelho; Francisco Albuquerque; André Grazina; Tiago Mendonça; António Fiarresga; Rúben Ramos; Mário Oliveira; Rui Cruz Ferreira; Duarte Cacela
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif">Background:</span></span></strong><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif"> Conduction disturbances requiring permanent pacemaker implantation (PPI) are a common complication of Transcatheter Aortic Valve Replacement (TAVR). Recently, it has been suggested that pacing dependency may decrease over time.</span></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif">Purpose: </span></span></strong><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif">To evaluate the dynamic evolution and predictors of adequacy of PPI after TAVR through an analysis of the ventricular pacing rate (VPR) and pacemaker dependency (PD) during the first year after PPI.</span></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif">Methods: </span></span></strong><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif">A retrospective analysis of all patients who underwent TAVR until November 2023 in one high-volume tertiary care center in Portugal was conducted. The VPR of the patients that were submitted to PPI after TAVR was analyzed at 3 distinct moments; during hospitalization, 1 month and 1 year after PPI. PMD was defined using a VPR cut-off of 80%. Patients with previous PPI, indication for PPI pre-TAVR and indication for cardiac resynchronization therapy were excluded.</span></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif">Results:</span></span></strong><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif"> Of the 971 patients included, <em>de novo</em> PPI was conducted in 199 cases (implantation rate - 22.2%), on average 4 days after TAVR. VPR analysis showed a bimodal distribution, with rates predominantly over 80% and below 20%, with a reduction in VPR over time (<strong>FIGURE 1</strong>). During hospitalization, 57.7% of patients had a VPR over 80% and 17.6% had a VPR of less than 20% (median VPR of 99%). At 1 month, 46.7% had a VPR over 80% and 24.7% had a VPR of less than 20% (median VPR of 80%). Finally, at 1 year, only 33% had a VPR over 80% and 27.5% had a VPR of less than 20% (median VPR of 55%). Approximately 30% of the cases were “pacemaker dependent” in all the evaluations and 20% were “never dependent”. Previous complete right bundle branch block, occurrence of complete AV block and earlier PPI (especially within the first 24 hours) were significantly correlated with PMD across all VPR evaluations, with complete AV block during TAVR procedure being the sole independent predictive factor (OR 3.638 [95% CI: 1.388 - 9.533]; p=0.009).</span></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif">Conclusion:</span></span></strong><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif"> In a large cohort of P receiving PPI after TAVR, VPR and PD diminished over time during the first year of follow-up. Complete AV block during TAVR was the most powerful predictor of long-term PD.</span></span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site